Our flagship programme is designed to help the best companies and talented founders. We have thrown the rule book away and redesigned the traditional accelerator model with a specific focus on health and healthcare. Our objective is to help you raise investment and close sales as quickly as possible.
HS. partners with key multi-national companies with active sales channels in health, healthcare and health insurance and enables them to connect with commercially-viable innovative health tech companies and integrate them into their supply chains.
We understand that for large corporations it can be almost impossible to find the best companies and products to help them solve key problems. We do the hard work for you, ensuring product-market fit, that the company can scale and that there is a health economics case behind any procurement decision.
HS. portfolio company Feebris has announced a successful seed investment raise of £1.1 million. The funding enables the company to continue its innovation in AI for precision diagnosis of respiratory conditions in elderly patients in the UK and young children in India.
James is joined by Mir Imran, an Indian healthtech inventor, entrepreneur and venture capitalist who has had >20 device companies, >400 patents and has sold companies to the likes of Ely Lily and Medtronic.
In association with the UK Business Angels Association and British Venture Capital Association, HS. presented a fantastic investor only Investor Summit - a half-day educational event focusing on industry trends, investment opportunities and look ahead at what emerging technologies will shape the sector.
Stay updated with our latest info. Join the HS. Community
Thanks for subscribing
HS.. © 2019 | Contact Us | Privacy Policy | Terms of Use
